Please sign in to follow a disease.
Cleerly, Inc.
Clinical trials sponsored by Cleerly, Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- AI heart scan trial aims to sharpen diagnosis of clogged arteries Results expected Dec 2026 (estimated)
- 15,000-Person study aims to sharpen heart risk predictions with CT scans Results expected Jun 2027 (estimated)
-
AI heart scan trial aims to sharpen diagnosis of clogged arteries
Diagnosis OngoingThis study compares a new AI-based method of analyzing CT scans of the heart to standard care for people with symptoms that might be coronary artery disease. The goal is to see if the AI approach helps doctors diagnose the condition more accurately, control risk factors like chol…
Sponsor: Cleerly, Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 13:03 UTC
-
15,000-Person study aims to sharpen heart risk predictions with CT scans
Knowledge-focused By invitation onlyThis study is enrolling 15,000 adults who are already scheduled for a coronary CT angiography (CCTA) scan. Researchers will analyze the scan images along with participants' health outcomes over time. The goal is to see if detailed information from the scans can help doctors more …
Sponsor: Cleerly, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC